Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

• Lihua E. Budde,

  Affiliations Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, United States of America, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Departments of Medicine and Bioengineering, University of Washington, Seattle, Washington, United States of America

  ⨯
• Carolina Berger,

  Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Yukang Lin,

  Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Jinjuan Wang,

  Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Xubin Lin,

  Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Shani E. Frayo,

  Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Shaunda A. Brouns,

  Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• David M. Spencer,

  Affiliations Pathology and Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Bellicum Pharmaceuticals, Inc., Houston, Texas, United States of America

  ⨯
• Brian G. Till,

  Affiliations Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Departments of Medicine and Bioengineering, University of Washington, Seattle, Washington, United States of America

  ⨯
• Michael C. Jensen,

  Affiliations Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, United States of America

  ⨯
• Stanley R. Riddell,

  Affiliations Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Departments of Medicine and Bioengineering, University of Washington, Seattle, Washington, United States of America, Institute for Advanced Study, Technical University of Munich, Munich, Germany

  ⨯
• Oliver W. Press

  * E-mail: press@uw.edu

  Affiliations Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Departments of Medicine and Bioengineering, University of Washington, Seattle, Washington, United States of America

  ⨯